Highest Quality, Lowest Risk
Site identification and activation are critical components of clinical trials and have a significant impact on subsequent trial timelines. At ClinActis, we understand the importance of an expedient and efficient approach to ensure the highest quality and lowest risk to your trial.
Our experienced clinical research associates (CRAs) are skilled and well-trained in clinical research, providing the highest quality review of data and effective communication with study sites. We leverage our extensive network of industry contacts and regional knowledge to identify the most suitable sites for your study, ensuring that your trial remains on time, on budget, and conducted to the highest quality level possible.
We follow a comprehensive site identification and activation process that includes site feasibility assessments, site selection, site initiation visits, and regulatory submissions. Our approach is designed to minimize delays and ensure that your trial is up and running as quickly as possible.
Our CRAs conduct on-site monitoring visits throughout the study to:
Oversee data collection.
Review source documentation and case report forms.
Ensure regulatory compliance.
Resolve data queries.
Conduct interim analyses as requested by the client.
At ClinActis, we are committed to delivering high-quality and efficient site identification and activation services to our clients. Contact us today to learn more about how we can support your clinical research needs and help you achieve the best possible results for your trial.